Gage Cannabis Expands COOKIES Retail Footprint In Michigan, Opening Its Seventh Dispensary In The State
Ryan Allway March 5th, 2021 News, Top News Gage Cannabis Co. (“Gage” or the “Company”), a leading high-quality cannabis brand and operator in Michigan, announced it will begin serving adult-use consumers at its second COOKIES provisioning center in Kalamazoo starting on Saturday, March 6; the announcement comes quickly after... Read more
Tryp Therapeutics Announces Application to List on OTCQB
Ryan Allway March 4th, 2021 Psychedelics, Top News Tryp Therapeutics (CSE: TRYP) (“Tryp” or the “Company”) a pharmaceutical company focused on identifying and developing clinical-stage compounds for diseases with high unmet medical needs, announced today that it has submitted its application for a listing to the OTCQB® Venture Market... Read more
UPDATE — Revive Therapeutics Provides Update on FDA Phase 3 Clinical Trial for Bucillamine in COVID-19 with Planned Completion and Emergency Use Authorization Request
Ryan Allway February 26th, 2021 News, Top News TORONTO, Feb. 26, 2021 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce... Read more
Clever Leaves Added to NYSE-Listed Cannabis ETF ‘THCX’
Ryan Allway February 18th, 2021 News, Top News NEW YORK, Feb. 17, 2021 (GLOBE NEWSWIRE) — Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multi-national operator and licensed producer of pharmaceutical-grade cannabinoids, announced today it has been added to the Cannabis ETF (NYSE: THCX) (“THCX”),... Read more
Ryan Allway February 18th, 2021 News, Top News CALGARY, AB, Feb. 17, 2021 /CNW/ – Inner Spirit Holdings Ltd. (“Inner Spirit” or the “Company“) (CSE: ISH), a Canadian company that has established a national network of Spiritleaf cannabis retail stores, today announced  it has entered into a letter of engagement with... Read more
AIkido Pharma Enters Into Letter Of Intent With Silo Pharma for Use of Psilocybin and Peptide Therapy for Cancer Treatment
Ryan Allway February 16th, 2021 Psychedelics, Top News NEW YORK, Feb. 16, 2021 /PRNewswire/ — AIkido Pharma Inc. (Nasdaq: AIKI) (“AIkido” or the “Company”) today announced the execution of a Letter of Intent with Silo Pharma Inc. (“Silo”) to grant to AIkido a worldwide, exclusive sublicense for use of peptide therapy, combined with psilocybin, in the therapeutic... Read more
TILT Holdings Inc. Announces Exclusive Contract to Manufacture and Distribute Her Highness NYC Branded Products in Massachusetts
Ryan Allway February 5th, 2021 News, Top News Dedicated to Delivering Experiences that Elevate and Celebrate Women, Her Highness NYC is a Female-Owned, Premium Cannabis Brand with a Portfolio of Products Inspired and Engineered by Women for Women In Partnership with TILT’s Subsidiary, Commonwealth Alternative Care, Her Highness’ Launch... Read more
Ayr Strategies Moves to Definitive Merger Agreement with Blue Camo, LLC (Arizona) Expected Closing in Late March Author of the article:
Ryan Allway January 28th, 2021 News, Top News TORONTO, Jan. 27, 2021 (GLOBE NEWSWIRE) — Ayr Strategies Inc. (CSE: AYR.A, OTCQX: AYRWF) (“Ayr” or the “Company”), a leading vertically integrated cannabis multi-state operator, has signed a Definitive Agreement to acquire the membership interests of Blue Camo, LLC, following the... Read more
Red White & Bloom and High Times® Respond to Demand with Second Release of Branded Cannabis Products in Michigan under Exclusive License
Ryan Allway January 27th, 2021 News, Top News – High Times initial release sold out in hours – – This second release will be available in 30 dispensaries throughout Michigan – TORONTO, Jan. 27, 2021 (GLOBE NEWSWIRE) — Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) (“RWB” or “Red White... Read more
Mydecine Innovations Group Files Application to list to the NASDAQ
Ryan Allway January 27th, 2021 Psychedelics, Top News DENVER, Jan. 27, 2021 (GLOBE NEWSWIRE) — Mydecine Innovations Group (CSE: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company’), an emerging biopharma and life sciences company committed to the research, development, and acceptance of alternative nature-sourced medicine for mainstream use,... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )